LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.12 | 21.74 | 12489 | 6211 | 2.0105 | 1.1787 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.09 | 21.74 | 511 | 6201 | 0.0824 | 0.4727 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.09 | 21.74 | 9671 | 6201 | 1.5595 | 1.1120 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.09 | 21.74 | 57 | 6201 | 0.0092 | 0.1255 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.09 | 21.74 | 12734 | 6201 | 2.0534 | 1.1845 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.06 | 21.74 | 328 | 6152 | 0.0533 | 0.3954 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.06 | 21.74 | 9930 | 6152 | 1.6141 | 1.1211 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.06 | 21.74 | 14 | 6152 | 0.0023 | -0.0526 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.06 | 21.74 | 12851 | 6152 | 2.0889 | 1.1893 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.03 | 21.74 | 289 | 6155 | 0.0470 | 0.3739 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.03 | 21.74 | 10117 | 6155 | 1.6436 | 1.1258 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.03 | 21.74 | 58 | 6155 | 0.0094 | 0.1280 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.03 | 21.74 | 13100 | 6155 | 2.1282 | 1.1943 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.00 | 21.74 | 198 | 6081 | 0.0326 | 0.3123 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.00 | 21.74 | 10394 | 6081 | 1.7091 | 1.1363 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.00 | 21.74 | 8 | 6081 | 0.0013 | -0.1157 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.00 | 21.74 | 13265 | 6081 | 2.1812 | 1.2014 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.97 | 21.74 | 95 | 6084 | 0.0156 | 0.1989 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.97 | 21.74 | 10582 | 6084 | 1.7392 | 1.1409 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.97 | 21.74 | 18 | 6084 | 0.0030 | -0.0230 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 89.97 | 21.74 | 13518 | 6084 | 2.2217 | 1.2064 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.94 | 21.74 | 57 | 6121 | 0.0093 | 0.1258 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.94 | 21.74 | 10744 | 6121 | 1.7550 | 1.1431 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.94 | 21.74 | 52 | 6121 | 0.0085 | 0.1131 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 91.94 | 21.74 | 13832 | 6121 | 2.2594 | 1.2107 | MN20160310_N01 | K18 |